Neo Ivy Capital Management Stryker Corp Transaction History

Neo Ivy Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$194.09 - $276.37 $16,885 - $24,044	87 New	87 $17,000
Q4 2021 Feb 15, 2022	SELL	$236.63 - $276.44 $1.02 Million - $1.19 Million	-4,294 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$248.9 - $280.09 $1.05 Million - $1.18 Million	4,230 Added 6609.38%	4,294 $774,000
Q2 2021 Aug 16, 2021	SELL	$242.95 - $267.0 $229,344 - $252,048	-944 Reduced 93.65%	64 $17,000
Q1 2021 Oct 07, 2021	BUY	$221.01 - $248.82 $222,778 - $250,810	1,008 New	1,008 $246,000
Q2 2020 Aug 17, 2020	SELL	$144.67 - $207.03 $621,212 - $888,986	-4,294 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$144.67 - $207.03 $578,245 - $827,498	3,997 Added 1345.79%	4,294 $774,000
Q1 2020 May 15, 2020	BUY	$126.5 - $225.1 $37,570 - $66,854	297 New	297 $49,000

2,171

286M

1.13M

1.1M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.